LivaNova Appoints Stefano Folli to Lead $800M Cardiopulmonary Division
Stefano Folli will become President, Cardiopulmonary at LivaNova effective June 1, partnering with retiring Franco Poletti through July 31 before assuming full control. He will join the executive leadership team reporting to CEO Vladimir Makatsaria and oversee strategic growth of the nearly $800 million cardiopulmonary disposables and equipment business.
1. Appointment Details
Stefano Folli will join LivaNova as President, Cardiopulmonary on June 1, working alongside Franco Poletti until his retirement on July 31. Following the transition, Folli assumes full responsibility for the cardiopulmonary business and will report directly to CEO Vladimir Makatsaria as a member of the executive leadership team.
2. Cardiopulmonary Business Unit Overview
The cardiopulmonary division generates nearly $800 million in annual revenue and offers a complete range of disposables and equipment, including the Essenz™ Perfusion System. Folli’s mandate includes driving strategic growth, enhancing operational execution and accelerating product innovation to strengthen market position.
3. Executive Leadership Background
Folli brings over three decades of healthcare and medtech experience, most recently serving as Executive Vice President and Global President of Ambulatory Monitoring & Diagnostics at Philips. His prior roles include head of global services and solutions delivery and CEO of regional Philips units, underscoring his track record in integrating acquisitions and expanding market leadership.